Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register

1. Dreijer, AR, Diepstraten, J, Brouwer, R, et al. Risk of bleeding in hospitalized patients on anticoagulant therapy: prevalence and potential risk factors. Eur J Intern Med 2019; 62: 17–23.
Google Scholar | Crossref | Medline2. Palareti, G, Leali, N, Coccheri, S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423–428.
Google Scholar | Crossref | Medline | ISI3. Palareti, G, Antonucci, E, Migliaccio, L, et al. Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago. Intern Emerg Med 2017; 12: 1109–1119.
Google Scholar | Crossref | Medline4. Ogunsua, AA, Touray, S, Lui, JK, et al. Body mass index predicts major bleeding risks in patients on warfarin. J Thromb Thrombolysis 2015; 40: 494–498.
Google Scholar | Crossref | Medline5. Ageno, W, Gallus, AS, Wittkowsky, A, et al. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(Suppl. 2): e44S–e88S.
Google Scholar | Crossref | Medline | ISI6. Alotaibi, GS, Almodaimegh, H, McMurtry, MS, et al. Do women bleed more than men when prescribed novel oral anticoagulants for venous thromboembolism? A sex-based meta-analysis. Thromb Res 2013; 132: 185–189.
Google Scholar | Crossref | Medline7. Loffredo, L, Violi, F, Perri, L. Sex related differences in patients with acute venous thromboembolism treated with new oral anticoagulants. A meta-analysis of the interventional trials. Int J Cardiol 2016; 212: 255–258.
Google Scholar | Crossref | Medline8. Dentali, F, Sironi, AP, Gianni, M, et al. Gender difference in efficacy and safety of nonvitamin K antagonist oral anticoagulants in patients with nonvalvular atrial fibrillation or venous thromboembolism: a systematic review and a meta-analysis of the literature. Semin Thromb Hemost 2015; 41: 774–787.
Google Scholar | Crossref | Medline9. Brekelmans, MP, Scheres, LJ, Bleker, SM, et al. Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin. Thromb Haemost 2017; 117: 809–815.
Google Scholar | Crossref | Medline10. Scheres, L, Brekelmans, M, Ageno, W, et al. Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study. BJOG 2018; 125: 1581–1589.
Google Scholar | Crossref | Medline11. Huisman, MV, Ferreira, M, Feuring, M, et al. Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism. J Thromb Haemost 2018; 16: 1775–1778.
Google Scholar | Crossref | Medline12. Weaver, J, Shoaibi, A, Truong, HQ, et al. Comparative risk assessment of severe uterine bleeding following exposure to direct oral anticoagulants: a network study across four observational databases in the USA. Drug Saf 2021; 44: 479–497.
Google Scholar | Crossref | Medline13. Antonucci, E, Poli, D, Tosetto, A, et al. The Italian START-Register on anticoagulation with focus on atrial fibrillation. PLoS ONE 2015; 10: e0124719.
Google Scholar | Crossref | Medline14. von Elm, E, Altman, DG, Egger, M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573–577.
Google Scholar | Crossref | Medline | ISI15. Ageno, W, Mantovani, LG, Haas, S, et al. Patient management strategies and long-term outcomes in isolated distal deep-vein thrombosis versus proximal deep-vein thrombosis: findings from XALIA. TH Open 2019; 3: e85–e93.
Google Scholar | Crossref | Medline16. Cockcroft, DW, Gault, MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41.
Google Scholar | Crossref | Medline | ISI17. National Kidney Foundation . K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2, Suppl. 1): S1–S266.
Google Scholar | Medline | ISI18. Schulman, S, Kearon, C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692–694.
Google Scholar | Crossref | Medline | ISI19. Kaatz, S, Ahmad, D, Spyropoulos, AC, et al. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 2015; 13: 2119–2126.
Google Scholar | Crossref | Medline | ISI20. Boonyawat, K, Lensing, AWA, Prins, MH, et al. Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: comparison of high- and low-dose rivaroxaban with aspirin. Res Pract Thromb Haemost 2021; 5: 308–313.
Google Scholar | Crossref | Medline21. Moustafa, F, Fernandez, S, Fernandez-Capitan, C, et al. Uterine bleeding during anticoagulation in women with venous thromboembolism. Thromb Res 2017; 151(Suppl. 1): S1–S5.
Google Scholar | Crossref | Medline22. Beyer-Westendorf, J, Michalski, F, Tittl, L, et al. Vaginal bleeding and heavy menstrual bleeding during direct oral anti-Xa inhibitor therapy. Thromb Haemost 2016; 115: 1234–1236.
Google Scholar | Crossref | Medline23. Krause, M, Henningsen, A, Torge, A, et al. Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism. Thromb Res 2016; 148: 145–151.
Google Scholar | Crossref | Medline24. Bryk, AH, Pirog, M, Plens, K, et al. Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism. Vascul Pharmacol 2016; 87: 242–247.
Google Scholar | Crossref | Medline25. Palareti, G, Cosmi, B, Antonucci, E, et al. Duration of anticoagulation after isolated pulmonary embolism. Eur Respir J 2016; 47: 1429–1435.
Google Scholar | Crossref | Medline26. Palareti, G, Antonucci, E, Dentali, F, et al. Patients with isolated pulmonary embolism in comparison to those with deep venous thrombosis. Differences in characteristics and clinical evolution. Eur J Intern Med 2019; 69: 64–70.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif